Questions with the most recent answer or edit.
The case in front of me: 95.2% · VendorInvestigate · 96.4% · Janoshik. I would like the axes of comparison first and the recommendation second. I have tried the first…
Setup, so nobody has to ask: 5 mg · 0.5 mL. The units are where I keep going wrong, so please be explicit about them. I have sanity-checked the order of magnitude and…
The specifics, since they change the answer: 50 mg · 2 mL · phosphate-buffered diluent · retatrutide. I am at the decision point and I would rather think it through…
Numbers first: SGN · Suzhou · Germany. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum viable…
What I am working with: ERP · SGN · New Zealand. I suspect the honest answer is that it depends, in which case I would like to know on what. Assume I can obtain…
I would like to know what to measure as much as what to do. Everything I have found on this is either a forum aside or a product page, neither of which I trust. I am…
Numbers first: reflux · orforglipron · TRIUMPH-3. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone…
Concretely: oxidation · liraglutide · 4 °C. I want to know whether this is a real physical effect or an artefact of how it is measured. What prompted the question is…
Stated plainly: WXT · ChinaPeptides (QYAOBIO). I suspect the honest answer is that it depends, in which case I would like to know on what. Assume I can obtain either…
What I am working with: 37 °C · a GLP-1 receptor agonist. This is asserted often enough that I assumed it was established, and then I went looking for the source. I…
What I am working with: +3 · 4731.3 Da. The units are where I keep going wrong, so please be explicit about them. I have sanity-checked the order of magnitude and it…
The lot number on the vial matches the certificate, which at least rules out the easy problem. I have done this once and I suspect I got away with it rather than got…
The specifics, since they change the answer: STEP 8 · nausea · 30 mg. I want to understand what this actually establishes, as opposed to what it is being used to…
What I have: 3.33 mg/mL · retatrutide. I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a defensible reason…
For reference: 5 mg/mL · ecnoglutide. The comparison I want does not seem to exist anywhere in a form I can evaluate. I have read the arguments for each and they do…
The specifics, since they change the answer: dizziness · survodutide. I would like the mechanism, because I want to be able to reason about the cases nobody has…
The specifics, since they change the answer: dizziness · ecnoglutide · REDEFINE-1. I have the document in front of me and I can read the numbers. What I cannot do is…
Concretely: STEP 4 · tirzepatide. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single result, which…
Numbers first: a 31G needle · retatrutide · 20 mg/mL. I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a…
What I have: four · 1,200 kcal. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum viable version,…
Numbers first: cagrilintide · Chengdu. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum viable…
Concretely: 96.8% · VendorInvestigate · 99.4%. I think I have a problem. I am not yet sure whether it is a real problem or a measurement artefact. I want to know…
What I have: 30 mg · dulaglutide. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this may have a boring answer. I would still…
I have kept every message, invoice and document, which I gather is the useful habit. I would rather be corrected now than propagate something wrong. I am specifically…